Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Spark Therapeutics Inc (ONCE)’

trade, forex, investment, gain, stock, phone, network, view, report, money, smart, background, broker, market, laptop, table, economy, display, loss, business, urban,

Hedge Fund and Insider Trading News: Carl Icahn, Tom Steyer, Bill Ackman, Simpson Manufacturing Co, Inc. (SSD), Spark Therapeutics Inc (ONCE), and More

Carl Icahn Says He hasn’t Talked to Trump Since August (CNBC) Billionaire investor Carl Icahn said Tuesday that he hasn’t spoken with President......(read more)
Countries With Highest Medical Research Spending

Zogenix Inc. (ZGNX) and Arena Pharmaceuticals, Inc. (ARNA) Helped This Healthcare-Focused Fund Earn Double-Digit Returns

It’s no secret that hedge funds have been underperforming the market by quite a wide margin in the last couple of years. However, in the industry......(read more)
HedgeFundSentimentChart

Spark Therapeutics Inc (ONCE) and Other Profitable Healthcare Picks of Casdin Capital

At Insider Monkey, we track some 750 hedge funds and other institutional investors. We analyze their 13F filings and determine stocks that they are collectively......(read more)
Insider Trading Back

Most Insiders Tend To Buy Stock At The Right Time And Here Is Some Proof

The Dow Jones Industrial Average has closed in the green for six straight trading sessions and continues its recovery from the recent correction. Similarly......(read more)
Sergey Nivens/shutterstock.com

Deerfield Management Bets Big On Company It Polished Ahead Of IPO, Nivalis Therapeutics Inc (NVLS)

Following the initial public offering of Nivalis Therapeutics Inc (NASDAQ:NVLS) today, James E. Flynn‘s Deerfield Management, which was a stakeholder......(read more)
Ascendis Phrama (ASND)

Ascendis Pharma A/S (ASND): Orbimed Advisors Takes Activist Stake in Newly Public Company

Samuel Isaly’s Orbimed Advisors has taken an activist stake in the recently listed Ascendis Pharma A/S (NASDAQ:ASND), an early-stage drug company working......(read more)